Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
MBOT
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?
Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo authorization for its OTTAVA robotic surgical system. The authorization represents an important milestone for J&J's…
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Pelagos Insurance Capital Limit PLGO: This insurance and reinsurance company has seen the Zacks Consensus Estimate for its current year earnings increasing 7% over th…
Why Is Sanmina (SANM) Stock Soaring Today What Happened? Shares of electronics manufacturing services company Sanmina (NASDAQ:SANM) jumped 5.4% in the afternoon session after Microbot Medical selected it as a manufacturing partner for its…
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader
Microbot Medical Inc. Expanding manufacturing capabilities is part of the Company's cost reduction strategy and supports global expansion HINGHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and…
Cencora to Report Q2 Earnings: What's in Store for the Stock?
Cencora COR is slated to report second-quarter fiscal 2026 results on May 6, before market open. In the last reported quarter, the company delivered an earnings surprise of 0.25%. COR’s earnings beat estimates in each of the trailing four…
Solventum to Post Q1 Earnings: Is a Beat Likely for the Stock?
Solventum SOLV is scheduled to release first-quarter 2026 results on May 5, after market close. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 4.67%. SOLV delivered a trailing four-quarter average…
DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock?
DENTSPLY SIRONA Inc. XRAY is scheduled to release first-quarter 2026 results on May 5, after market close. In the last reported quarter, the company’s earnings missed the Zacks Consensus Estimate by 3.57%. It delivered an average earnings…
Can Strong Growth Aid INNV's Q3 Earnings Amid Margin Seasonality?
InnovAge INNV is scheduled to release third-quarter fiscal 2026 results on May 05, after market close. In the last reported quarter, the company delivered an earnings surprise of 100.00%. The company appears to have entered the second half…
Revvity to Report Q1 Earnings: What's in Store for the Stock?
Revvity, Inc. RVTY is slated to report first-quarter 2026 results on May 05, before market open. In the last reported quarter, the company delivered an earnings surprise of 4.29%. RVTY’s earnings beat estimates in each of the trailing four…
Stryker to Report Q1 Earnings: What's in Store for the Stock?
Stryker Corporation SYK is scheduled to release first-quarter 2026 results on April 30, after market close. In the last reported quarter, the company delivered an earnings surprise of 1.59%. Q1 Estimates The Zacks Consensus Estimate for ea…
Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1?
DexCom, Inc. DXCM is scheduled to report first-quarter 2026 results on April 30, after the closing bell. In the last reported quarter, the company’s adjusted earnings per share (EPS) of 68 cents surpassed the Zacks Consensus Estimate by 4.…
Microbot Medical Begins Full U.S. Launch of LIBERTY System
Microbot Medical MBOT recently announced the successful completion of the limited market release of its LIBERTY Endovascular Robotic System and the planned transition to full market release in the United States. The system has already been…
Truffle Capital Unveils the First Edition of the Truffle MedTech 10
PARIS, March 18, 2026--(BUSINESS WIRE)--Truffle Capital, a leading European venture capital firm whose mission is to support the creation and growth of companies capable of becoming global leaders, unveils the Truffle MedTech 10 index. Thi…
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks were lower late Wednesday afternoon, with the NYSE Health Care Index easing 0.1% PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
Sector Update: Health Care Stocks Mixed in Afternoon Trading
Health care stocks were mixed Wednesday afternoon, with the NYSE Health Care Index up 0.1% and the H PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
HINGHAM, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, announced that Emory University Hospital, a nationally recognized acad…
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
Company Completes the Required Infrastructure to Support the Introduction of LIBERTY® to the U.S. Market with the Hiring of the Core Commercial Team and Establishing Logistic Partnership Interest and Overwhelmingly Positive Feedback from P…
Intuitive Surgical, Inc. (ISRG): A Bull Case Theory
We came across a bullish thesis on Intuitive Surgical, Inc. on Sustainable’s Substack by SustainableGrowth. In this article, we will summarize the bulls’ thesis on ISRG. Intuitive Surgical, Inc.'s share was trading at $440.94 as of October…
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
First U.S. Based Medical Meeting Presence Post-FDA Clearance Will Allow the Company to Commercially Engage Future Potential Users of the LIBERTY® System Company Completes the Recruitment of its Commercial Leadership Team as it Remains On T…
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
The Experienced MedTech Logistics Provider Will Help Ensure Effective and Efficient Inventory Management and Customer Support The Company is on Track to Commence the Launch of LIBERTY® during Q4 This Year HINGHAM, Mass., Oct. 14, 2025 (GLO…
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
HINGHAM, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) (“Microbot” or the “Company”), today announced the third and final closing of its previously announced exercise of certain outstanding preferred investm…
In trading on Tuesday, shares of Sonos Inc (Symbol: SONO) touched a new 52-week high of $15.95/share. That's a 109.32% rise, or $8.33 per share from the 52-week low of $7.62 set back on 04/16/2025. That means at today's intraday high, any…
Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
HINGHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY® Endovascular Robotic System, announces that its Chief Executive Officer, Harel Gadot, will be in…
Microbot (MBOT) Extends 4-Day Decline on $63-Million Fundraising Program
We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive session on Thursday, shedding 6.93 per…
Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
HINGHAM, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) (“Microbot” or the “Company”), today announced the first closing of its previously announced exercise of certain outstanding preferred investment optio…
Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. [gap] TOP GAP UP STOCKS TICKER CHANGE COMMENT NAOV [https://www.char…
Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System
Microbot Medical Inc. MBOT recently received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, marking a major regulatory milestone for the company. The LIBERTY system is designed to provide physicians with improved control…
REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference
HINGHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY® Endovascular Robotic System, today announced that Harel Gadot, CEO, President & Chairman, will h…
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
Accelerated Launch Readiness Plans Position Company for Commercialization during Q4 2025 The Company’s Initial Addressable Market Includes Approximately 2.5 Million Peripheral Endovascular Procedures in the U.S. Annually CEO, President & C…
Brenmiller Energy appoints Harel Gadot as independent director to board
Brenmiller Energy Ltd . (NASDAQ:BNRG) announced Thursday the appointment of Harel Gadot as an independent director to its board, effective immediately. The decision was made by the company’s board of directors and fills a vacancy that will…
Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market
Microbot Medical Inc. MBOT has been granted a new U.S. patent that broadens the potential applications of its LIBERTY Endovascular Robotic System. The patent covers a modular design that allows interchangeable tool-receiver units, giving t…
Microbot Medical stock maintains Buy rating at H.C. Wainwright on patent win
Investing.com - Microbot Medical (NASDAQ:MBOT) maintained its Buy rating and $9.00 price target at H.C. Wainwright following a new patent grant for its LIBERTY endovascular robotic system. The stock has shown remarkable momentum, surging o…
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
With the Newly Granted IP, the Company’s IP Portfolio for the LIBERTY®System now includes 12 patents granted globally and 57 patent applications pending. The Company Continues to Scale Commercial Readiness Plans for the LIBERTY®System as i…
DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors
NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clin…
Microbot Medical appoints former Olympian as VP of sales
HINGHAM, Mass. - Microbot Medical Inc. (NASDAQ:MBOT), whose stock has surged over 130% in the past year, has appointed Christina Bailey as its new Vice President of Sales, according to a company press release issued Tuesday. Bailey, a two-…
Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales
Microbot Medical Inc. Company Continues to Strengthen Organizational Infrastructure with Success-Driven Medical Device Veteran Christina Bailey, VP of Sales, Microbot MedicalMicrobot Medical® Expands Commercial Leadership with Appointment…